Connect Sign In
ARUP’s central pathology review service has provided key support for the Cogent SUMMIT trial through robust laboratory testing, mastocytosis pathology expertise, and rigorous quality standards.
ARUP has launched a highly sensitive and fully automated molecular assay to detect hepatitis delta virus (HDV) that will facilitate better detection of the virus.
At upcoming conferences, ARUP experts will highlight a new blood-based biomarker assay for Alzheimer’s disease and share a presentation on building a successful laboratory outreach program.
ARUP experts have received recognition from ADLM and the ADLM Academy for their remarkable achievements this year, winning Young Investigator Merit and Distinguished Abstracts awards.
The latest edition offers a look at ARUP’s advancements in the use of artificial intelligence for ova and parasite testing, highlights the importance of genetic testing, and features lifesaving tests.
ARUP experts will present on a variety of emerging topics at the American Society for Microbiology (ASM) conference, ASM Microbe 2025, which will be held June 19–23, 2025, in Los Angeles.
New international clinical practice guidelines from the AABB and ICTMG recommend restrictive strategies to minimize the risk of adverse effects from platelet transfusions.
Join ARUP at the 2025 AAN Annual Meeting to explore the latest in diagnostic laboratory testing for autoimmune neurology, including a presentation on a new biomarker test for Alzheimer's disease.
Pramana, Inc., and ARUP are collaborating to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology.
ARUP will expand its AI-augmented screening tool for the detection of human gastrointestinal parasites to become first and only lab to apply AI to the entire ova and parasite testing process.
